Correlation Between Datalogic SpA and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Datalogic SpA and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Datalogic SpA and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Datalogic SpA and Takeda Pharmaceutical, you can compare the effects of market volatilities on Datalogic SpA and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Datalogic SpA with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Datalogic SpA and Takeda Pharmaceutical.

Diversification Opportunities for Datalogic SpA and Takeda Pharmaceutical

0.43

Correlation Coefficient

Datalogic SpA  Takeda Pharmaceutical

Very weak diversification

The 3 months correlation between Datalogic and Takeda is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Datalogic SpA and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Datalogic SpA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Datalogic SpA are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Datalogic SpA i.e., Datalogic SpA and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Datalogic SpA and Takeda Pharmaceutical

Assuming the 90 days trading horizon Datalogic SpA is expected to under-perform the Takeda Pharmaceutical. In addition to that, Datalogic SpA is 1.7 times more volatile than Takeda Pharmaceutical. It trades about -0.13 of its total potential returns per unit of risk. Takeda Pharmaceutical is currently generating about -0.02 per unit of volatility. If you would invest  1,300  in Takeda Pharmaceutical on September 20, 2024 and sell it today you would lose (30.00) from holding Takeda Pharmaceutical or give up 2.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.31%
Values	Daily Returns

Datalogic SpA  vs.  Takeda Pharmaceutical

Datalogic SpA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Datalogic SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Datalogic SpA and Takeda Pharmaceutical

The main advantage of trading using opposite Datalogic SpA and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Datalogic SpA position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Datalogic SpA and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.